The Canadian Press reports: "Health Canada has approved the first human trial of an experimental cancer drug called dichloroacetate, or DCA, in people with an advanced form of an aggressive brain cancer. The molecule has drawn international attention after the University of Alberta's Dr. Evangelos Michelakis published promising results in January showing it significantly shrunk tumours in rats. This new trial will give doctors a clue as to whether the research's impressive results will make the jump into human subjects."
I have recently been following articles about Dichloroacetate (DCA) because it MIGHT be a promising cure for cancer. We will know more after the human trials have been completed.
No comments:
Post a Comment